Overview

PK,PD and DDI of Epaminurad and Naproxen in Healthy Volunteers

Status:
ENROLLING_BY_INVITATION
Trial end date:
2026-01-01
Target enrollment:
Participant gender:
Summary
A Phase 1 Study to evaluate the safety, PK/PD, drug-drug interaction(DDI) of Epaminurad and Naproxen in Healthy Volunteers
Phase:
PHASE1
Details
Lead Sponsor:
JW Pharmaceutical
Treatments:
Naproxen
URC102